Cann Group

Cann Group

Pharmaceutical Manufacturing

Melbourne, Victoria 8,992 followers

Our business is science, our product is quality of life

About us

Cann Group is a world-class business focused on breeding, cultivating, manufacturing and supplying medicinal cannabis for sale and use within Australia and approved export markets. Cann has established research, cultivation and GMP manufacturing facilities in Bundoora, in northern Melbourne, and a state-of-the-art large-scale cultivation and GMP manufacturing facility near Mildura, Victoria. Cann Group’s leading position in plant genetics, breeding, extraction, analysis and production techniques supports its objective to supply high quality, safe medicinal cannabis for a range of diseases and medical conditions. Incorporated in the Company's brand portfolio is its proprietary Satipharm delivery system for cannabinoids. Botanitech is a brand created by Cann and boasts a diverse, affordable and high-quality product range. The first stage of our new, state-of-the-art facility in regional Victoria is fully operational, with in-house analytical chemistry and microbiology laboratories, and the capacity to produce 12,500kg of high-quality flower per year, with subsequent stages planned in response to growing demand. We have extensive R&D collaborations with globally renowned agricultural and pharmaceutical research partners, and have developed our own exclusive, proprietary lines of high-yielding cultivars. Cann Group is committed to the future of high-quality, low-cost cannabis medicines, and the development of a reliable and trusted industry.

Industry
Pharmaceutical Manufacturing
Company size
51-200 employees
Headquarters
Melbourne, Victoria
Type
Public Company
Founded
2017
Specialties
Agriculture, Research, Life Sciences, Health, Cannabis, Medicinal Cannabis, and Cultivation

Locations

Employees at Cann Group

Updates

Similar pages

Browse jobs

Funding

Cann Group 1 total round

Last Round

Series A
See more info on crunchbase